Form 4: Eli Lilly Director Acquires Shares Through Deferral Plan

Mary Lynne Hedley, a director at Eli Lilly & Co, acquired 13 shares of common stock through a deferral plan, while also holding 98 shares indirectly through a trust.

Summary

• Mary Lynne Hedley, a director at Eli Lilly & Co, has reported a transaction involving the company's common stock.
• On April 15, 2024, Ms. Hedley acquired 13 shares of common stock at a price of $750.77 per share.
• These shares were acquired through the Lilly Directors' Deferral Plan, where stock units are deferred in lieu of cash compensation.
• The shares will be settled in common stock after Ms. Hedley's separation from service.
• Ms. Hedley also indirectly holds 98 shares of common stock through a trust.
• She disclaims beneficial ownership of these shares except to the extent of her pecuniary interest.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed neutrally to slightly positive as it aligns director interests with shareholders.

Positives

• The acquisition of shares by a director demonstrates confidence in the company's future.

Future Outlook

The acquired shares will be settled in common stock following the reporting person's separation from service.

Industry Context

This is a routine filing related to director compensation and is common practice for publicly traded companies.

Comparison to Industry Standards

• Director stock ownership and deferral plans are common across the pharmaceutical industry.
• Many companies use similar mechanisms to align director interests with shareholder value.
• The specific details of the deferral plan are unique to Eli Lilly, but the general concept is widely used.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns director interests with the company's performance.

Key Dates

Keywords

Eli Lilly, Director, Stock Acquisition, Deferral Plan, Common Stock, Beneficial Ownership, Mary Lynne Hedley